C. Michael Gibson, M.S., M.D.

C. Michael Gibson, M.S., M.D.

C. Michael Gibson, M.S., M.D.

Dr. Gibson is an interventional cardiologist, cardiovascular researcher, and educator who invented several of the measures of coronary blood flow that are widely used today.  He pioneered the “open artery hypothesis” as well our understanding of the importance of restoring flow downstream in the capillary bed in the “open microvasculature hypothesis” in heart attack patients.

Dr. Gibson is currently a full-time interventional cardiologist and Chief of Clinical Research in the Cardiovascular Division at Beth Israel Deaconess Medical Center, Harvard Medical School. Previously he was Director of the TIMI Data Coordinating Center at the Brigham and Women’s Hospital; Associate Chief of Cardiology and Director of Academic Affairs in the Cardiovascular Division at the Beth Israel Deaconess Medical Center; and prior to that held a variety of leadership roles at the Harvard Clinical Research Institute (HCRI), the University of California San Francisco (UCSF), Allegheny General Hospital and Harvard Medical School.

Over 25 years ago, he founded PERFUSE, an academic research organization for a wide variety of cardiovascular studies. Dr. Gibson also founded wikidoc.org and clinicaltrialresults.org, and served as medical lead in a partnership with Google, Microsoft and Yahoo to design a scheme of classifying medical content for the internet (schema.org) to improve medical search results. For four years in a row, Gibson has been chosen by his peers as one of Boston’s Top Doctors in Boston Magazine, as well as U.S. News & World Report.  Dr. Gibson received his B.S., M.S., and M.D. degrees from the University of Chicago. He was an Intern, Resident and Chief Resident at the Brigham and Women’s Hospital, Harvard Medical School.

For more information about InCarda: